Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
34,967,317
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
18,328,200
-
Shares change
-
+162,676
-
Total reported value, excl. options
-
$58,651,537
-
Value change
-
-$229,028
-
Put/Call ratio
-
16%
-
Number of buys
-
33
-
Number of sells
-
-21
-
Price
-
$3.20
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q3 2023
76 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q3 2023.
Apyx Medical Corp - Common Stock (APYX) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,328,200 shares
of 34,967,317 outstanding shares and own 52% of the company stock.
Largest 10 shareholders include Archon Capital Management LLC (3,452,030 shares), ROYCE & ASSOCIATES LP (2,009,600 shares), AIGH Capital Management LLC (1,895,231 shares), RTW INVESTMENTS, LP (1,777,194 shares), VANGUARD GROUP INC (1,479,913 shares), PURA VIDA INVESTMENTS, LLC (836,990 shares), Taylor Frigon Capital Management LLC (621,147 shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615,000 shares), BlackRock Inc. (498,415 shares), and Worth Venture Partners, LLC (462,606 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.